Skip to main content

European Journal of Nuclear Medicine and Molecular Imaging

Ausgabe 13/2015

Inhalt (18 Artikel)

Original Article

Feasibility and utility of re-treatment with 177Lu-DOTATATE in GEP-NENs relapsed after treatment with 90Y-DOTATOC

Stefano Severi, Maddalena Sansovini, Annarita Ianniello, Lisa Bodei, Silvia Nicolini, Toni Ibrahim, Valentina Di Iorio, Vincenzo D’Errico, Paola Caroli, Manuela Monti, Giovanni Paganelli

Original Article

The efficacy of 177Lu-labelled peptide receptor radionuclide therapy in patients with neuroendocrine tumours: a meta-analysis

Seong-Jang Kim, Kyoungjune Pak, Phillip J. Koo, Jennifer J. Kwak, Samuel Chang

Editorial

Current status and future perspectives of PSMA-targeted therapy in Europe: opportunity knocks

A. Pfestroff, M. Luster, C. A. Jilg, P. J. Olbert, C. H. Ohlmann, M. Lassmann, H. R. Maecke, S. Ezziddin, L. Bodei

Original Article

Pre-therapeutic dosimetry of normal organs and tissues of 177Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer

Levent Kabasakal, Mohammad AbuQbeitah, Aslan Aygün, Nami Yeyin, Meltem Ocak, Emre Demirci, Turkay Toklu

Open Access Original Article

Prognostic role of metabolic parameters of 18F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma

Myo Min, Peter Lin, Mark T. Lee, Ivan Ho Shon, Michael Lin, Dion Forstner, Victoria Bray, Andrew Chicco, Minh Thi Tieu, Allan Fowler

Original Article

Multiparametric PET imaging in thyroid malignancy characterizing tumour heterogeneity: somatostatin receptors and glucose metabolism

Tatjana Traub-Weidinger, Daniel Putzer, Elisabeth von Guggenberg, Georg Dobrozemsky, Bernhard Nilica, Dorota Kendler, Reto Bale, Irene Johanna Virgolini

Original Article

Long-term outcomes of 131Iodine mIBG therapy in metastatic gastrointestinal pancreatic neuroendocrine tumours: single administration predicts non-responders

Nicola Mulholland, Riddhika Chakravartty, Lindsey Devlin, Eleni Kalogianni, Ben Corcoran, Gillian Vivian

Original Article

FDG-PET/CT findings in systemic mastocytosis: a French multicentre study

S. Djelbani-Ahmed, M. O. Chandesris, A. Mekinian, D. Canioni, C. Brouzes, K. Hanssens, G. Pop, I. Durieu, S. Durupt, B. Grosbois, S. Besnard, O. Tournilhac, O. Beyne-Rauzy, P. Agapé, A. Delmer, D. Ranta, P. Y. Jeandel, S. Georgin-Lavialle, L. Frenzel, G. Damaj, V. Eder, O. Lortholary, O. Hermine, O. Fain, M. Soussan

Original Article

18 F-Alfatide II PET/CT in healthy human volunteers and patients with brain metastases

Chunjing Yu, Donghui Pan, Baoming Mi, Yuping Xu, Lixin Lang, Gang Niu, Min Yang, Weixing Wan, Xiaoyuan Chen

Original Article

A pilot study imaging integrin αvβ3 with RGD PET/CT in suspected lung cancer patients

Song Gao, Honghu Wu, Wenwu Li, Shuqiang Zhao, Xuepeng Teng, Hong Lu, Xudong Hu, Suzhen Wang, Jinming Yu, Shuanghu Yuan

Original Article

Gastric injury from 90Y to left hepatic lobe tumors adjacent to the stomach: fact or fiction?

Vanessa L. Gates, Ryan Hickey, Karen Marshall, Melissa Williams, Krystina Salzig, Robert J. Lewandowski, Riad Salem

Original Article

Difficulties in deciding whether to ablate patients with putatively “low–intermediate-risk” differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study

Savvas Frangos, Ioannis P. Iakovou, Robert J. Marlowe, Nicolaos Eftychiou, Loukia Patsali, Anna Vanezi, Androulla Savva, Vassilis Mpalaris, Evanthia I. Giannoula

Original Article

Clinical value of FDG-PET/CT in suspected paraneoplastic syndromes: a retrospective analysis of 137 patients

Stine Bjørn Kristensen, Søren Hess, Henrik Petersen, Poul Flemming Høilund-Carlsen

Original Article

The use of SPECT/CT for anatomical mapping of lymphatic drainage in vulvar cancer: possible implications for the extent of inguinal lymph node dissection

Angela Collarino, Maarten L. Donswijk, Willemien J. van Driel, Marcel P. Stokkel, Renato A. Valdés Olmos

Open Access Original Article

Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients

Elske Quak, Pierre-Yves Le Roux, Michael S. Hofman, Philippe Robin, David Bourhis, Jason Callahan, David Binns, Cédric Desmonts, Pierre-Yves Salaun, Rodney J. Hicks, Nicolas Aide

Review Article

99mTc-Annexin A5 quantification of apoptotic tumor response: a systematic review and meta-analysis of clinical imaging trials

Tarik Z. Belhocine, Francis G. Blankenberg, Marina S. Kartachova, Larry W. Stitt, Jean-Luc Vanderheyden, Frank J. P. Hoebers, Christophe Van de Wiele

Image of the Month

A case of Fahr’s disease examined by multi-modal imaging

Ferdinando Calabria, Gabriele Ciccariello, Carmela Falcone, Giuseppe Lucio Cascini, Orazio Schillaci